Literature DB >> 16981923

Effect of right ventricular apex pacing on the Tei index and brain natriuretic peptide in patients with a dual-chamber pacemaker.

Hitoshi Ichiki1, Naoya Oketani, Shuichi Hamasaki, Sanemasa Ishida, Tetsuro Kataoka, Masakazu Ogawa, Keishi Saihara, Hideki Okui, Tsuyoshi Fukudome, Takuro Shinasato, Takuro Kubozono, Yuichi Ninomiya, Takehiko Matsushita, Yutaka Otsuji, Chuwa Tei.   

Abstract

BACKGROUND: Asynchronous electrical activation induced by right ventricular apex (RVA) pacing can cause various abnormalities in left ventricular (LV) function, particularly in the context of severe LV dysfunction or structural heart disease. However, the effect of RVA pacing in patients with normal LV and right ventricular (RV) function has not been fully elucidated. The aim of this study was to characterize the effects of RVA pacing on LV and RV function by assessing isovolumic contraction time and isovolumic relaxation time divided by ejection time (Tei index) and by assessing changes in plasma brain natriuretic peptide (BNP).
METHODS: Doppler echocardiographic study and BNP measurements were performed at follow-up (mean intervals from pacemaker implantation, 44+/-75 months) in 76 patients with dual chamber pacemakers (sick sinus syndrome, n=30; atrioventricular block, n=46) without structural heart disease. Patients were classified based on frequency of RVA pacing, as determined by 24-hour ambulatory electrocardiogram (ECG) that was recorded just before echocardiographic study: pacing group, n=46 patients with RVA pacing>or=50% of the time, percentage of ventricular paced 100+/-2%; sensing group, n=30, patients with RVA pacing<50% of the time, percentage of ventricular paced 3+/-6%.
RESULTS: There was no significant difference in mean heart rate derived from 24-hour ambulatory ECG recordings when comparing the two groups (66+/-11 bpm vs 69+/-8 bpm). LV Tei index was significantly higher in pacing group than in sensing group (0.67+/-0.17 vs 0.45+/-0.09, P<0.0001), and the RV Tei index was significantly higher in pacing group than in sensing group (0.34+/-0.19 vs 0.25+/-0.09, P=0.011). Furthermore, BNP levels were significantly higher in pacing group than in sensing group (40+/-47 pg/mL vs 18+/-11 pg/mL, P=0.017). With the exception of LV diastolic dimension (49+/-5 mm vs 45+/-5 mm, P=0.012), there were no significant differences in other echocardiographic parameters, including left atrium (LA) diameter (35+/-8 mm vs 34+/-5 mm), LA volume (51+/-27 cm3 vs 40+/-21 cm3), LV systolic dimension (30+/-6 mm vs 29+/-7 mm), or ejection fraction (66+/-9% vs 63+/-11%), when comparing the two groups.
CONCLUSIONS: These findings suggest that the increase of LV and RV Tei index, LVDd, and BNP are highly correlated with the frequency of the RVA pacing in patients with dual chamber pacemakers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16981923     DOI: 10.1111/j.1540-8159.2006.00474.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  4 in total

1.  Selective site pacing: rationale and practical application.

Authors:  Sameer Parekh; Kenneth M Stein
Journal:  Curr Cardiol Rep       Date:  2008-09       Impact factor: 2.931

Review 2.  Epidemiology of Right Ventricular Dysfunction in Heart Failure with Preserved Ejection Fraction.

Authors:  Rosita Zakeri; Selma F Mohammed
Journal:  Curr Heart Fail Rep       Date:  2015-10

3.  Influence of atrioventricular optimization on hemodynamic parameters and quality of life in patients with dual chamber pacemaker with ventricular lead in right ventricular outflow tract.

Authors:  Artur Klimczak; Adam S Budzikowski; Marcin Rosiak; Marzenna Zielińska; Bożena Urbanek; Karol Bartczak; Michał Chudzik; Jerzy K Wranicz
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-03-06       Impact factor: 1.468

4.  Assessment of ventricular pacing in the setting of an institutional improvement program: insights into physiological pacing.

Authors:  Antoine Kossaify; Sylvana Zoghbi; Paul Milliez
Journal:  Clin Med Insights Cardiol       Date:  2012-03-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.